Spending like a bigger company on purpose: current results carry the cost of an expansion aimed at demand management say
The model's full reasoning — Q4 2015 call → NO1. The user asks to determine if management acknowledges that current results are weighed down by an expansion already undertaken, and justifies it by pointing to demand that is already real, based only on the transcript. 2. Let's analyze the transcript for the two required elements. * Element 1: The expansion is real, already underway, and visibly costing something now. * Look for descriptions of building, capacity, hiring, inventory, etc., and acknowledgment that this is weighing on current results. * Barry Davis: "we brought on an additional 100-million cubic feet of gas in a two-week period at our Cana plant to support Devon's production." (This is operational, not necessarily a cost burden). * Mike Garberding: "we financed approximately $4.5 billion worth of acquisitions and dropdowns." (This is financing, not necessarily a current-period cost burden). * Mike Garberding: "We expect consolidated growth capital expenditures to be around $445 million to $570 million for 2016, which will be spent on our core growth areas." (This is planned spending, not necessarily a current-period cost burden). * Mike Garberding: "we are expecting debt-to-adjusted EBITDA by year-end of 2016 of approximately 4.2 times [ph] based on our current financing plan." (This is a future expectation). * Steve Hoppe: "we are seeing a reduction in construction costs" (This is about future costs). * Mac Hummel: "we are seeing a reduction in construction costs" (same). * Let's look for a specific acknowledgment that the expansion is *currently* weighing on results. The transcript mentions "we are focused on executing on our plan" and "we have a strong balance sheet". It mentions "we are hyper focused on executing in our core growth areas." It mentions "we are seeing a reduction in construction costs" (future). It mentions "we are expecting debt-to-adjusted EBITDA by year-end of 2016 of approximately 4.2 times" (future). * Is there any statement like "our current EBITDA is depressed because of the costs of the new plants we are building"? No. The guidance is $770 million, which is higher than 2015's $728 million. They are not saying current results are being weighed down by expansion costs. They are saying they are executing on a plan. The costs are capital expenditures, not operating expenses that depress current EBITDA.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| PTLO | Portillo's Inc. | Q2 2023 | 2023-08-05 | B |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| KE | Kimball Electronics, Inc. | Q3 2023 | 2023-05-06 | C+ |
| SIBN | SI-BONE, Inc. | Q3 2022 | 2022-11-07 | C+ |
| CHE | Chemed Corporation | Q3 2022 | 2022-11-01 | B+ |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| WD | Walker & Dunlop, Inc. | Q2 2022 | 2022-08-09 | C+ |
| OGI | OrganiGram Holdings Inc. | Q3 2022 | 2022-07-14 | B+ |
| FLYW | Flywire Corporation | Q1 2022 | 2022-05-14 | B+ |
| HLIO | Helios Technologies, Inc. | Q1 2022 | 2022-05-10 | C |
| IRTC | iRhythm Technologies, Inc. | Q1 2022 | 2022-05-07 | C+ |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
| LMAT | LeMaitre Vascular, Inc. | Q3 2021 | 2021-10-29 | C+ |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| JBT | John Bean Technologies Corporation | Q2 2018 | 2018-07-26 | B |
| CP | Canadian Pacific Railway Limited | Q2 2018 | 2018-07-19 | B+ |
| AOSL | Alpha and Omega Semiconductor Limited | Q2 2018 | 2018-02-07 | B |
| IR | Ingersoll-Rand Plc | Q3 2017 | 2017-10-25 | B |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
SIBN · Q3 2022 → YESThe question is: Does management acknowledge that the company's CURRENT reported results are being visibly weighed down by the cost of an expansion the company has ALREADY undertaken — spending, hirin...YES Management explicitly describes the expansion as already underway and costing the company now: investments in sales force (85 territory managers + 72 specialists), new products (iFuse-TORQ, iFuse-Bedrock Granite), instrument trays, inventory, and R&D that are driving higher depreciation, freight, and product costs 84% gross margin (down low-single digits from these factors). Anshul confirms “we’ve made a substantial amount of investment whether it’s in TORQ trays or Granite trays or TORQ implants” and “this is going to lead to elevated depreciation,” while Laura notes the build supports “strong new product demand.
FLYW · Q1 2022 → YESThe question is: Does management acknowledge that the company's CURRENT reported results are being visibly weighed down by the cost of an expansion the company has ALREADY undertaken, AND justify carr...YES The transcript shows management explicitly linking the current EBITDA decline to the hiring expansion already completed ("increased the number of FlyMates by over 50% during the past year" and "added over 100 new FlyMates within the sales, marketing and product functions"), while framing the spending as a deliberate, ongoing 2022 investment plan that is already delivering observable results through record client adds (130), pipeline growth, and strong ARR signings.
EVGO · Q2 2022 → YESThe question is: Does management acknowledge that the company's CURRENT reported results are being visibly weighed down by the cost of an expansion the company has ALREADY undertaken, AND justify carr...YES Management describes concrete expansion already underway—170 stalls placed in Q2, total stalls at 2,397 with 460 under construction, pipeline at 3,669, CapEx jumped to $44 million to accelerate deployment, and G&A ramping personnel to support growth—while directly tying the resulting negative adjusted EBITDA of -$19.8 million to that deliberate build-out.